ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 702045 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 702045; 2) Community: the network communities that were significantly associated with the response to NSC 702045; 3) Molecule: the relationships between components within communities and NSC 702045; 4) MDR: the compounds that were significantly associated with the NSC 702045.

NSC Compound Enrichment Correlation
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.0135712240673828 0.56289892
NSC 730294 Null 0.0135712240673828 0.4654613
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0135712240673828 0.41111208
NSC 745957 2-Benzylthio-4-chloro-N-[imino(3,4,5-trimethylpyrazol-1-yl)methyl]-5-methylbenzenesulfonamide 0.0135712240673828 0.17976885
NSC 747448 3,19-(2,6-Dimethyoxy)benzylidineandrographolide 0.0135712240673828 0.44885384
NSC 749909 4-methoxy-2,6-bis[hydroxy(methyl)amino]-1,3,5-triazine 0.0135712240673828 0.18998512
NSC 755417 Null 0.0135712240673828 0.43515324
NSC 756471 SB-732941 0.0135712240673828 0.32239673
NSC 761997 Null 0.0135712240673828 0.16706966
NSC 86371 Quinolinium, 2-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1,6-dimethyl- iodide 0.0135712240673828 0.44720517
Total:141  Current:57    [First] [Prev] [Next] [Last]